Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo)

Toxicon

Volumn 36, Issue 12, 1998, Pages 1861-1869

  Chaves, Fernando ^a   León, Georgina ^a   Alvarado, Víctor Hugo ^a   Gutiérrez, José María ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

4 BROMOPHENACYL BROMIDE; DEXAMETHASONE; DIPHENHYDRAMINE; INDOMETACIN; PHOSPHOLIPASE A2; PRAZOSIN; SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL MODIFICATION; EDEMA; ENZYME ACTIVITY; FOOT PAD; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BOTHROPS; DEXAMETHASONE; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; FOOT; INDOMETHACIN; MICE; MUSCLE, SKELETAL; PHOSPHOLIPASES A; PLETHYSMOGRAPHY; PRAZOSIN; SNAKE VENOMS; TIME FACTORS;

EID: 0032403430     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(98)00107-X     Document Type: Article

References (38)

1. 2, on liposomes and mouse gastrocnemius muscle. Toxicon 31, 217-222.
2. 2 isolated from Bothrops asper (terciopelo) venom. Biochim. Biophys. Acta 1179, 253-259.
3. 2 paw edema in the mouse. Agents and Actions 27, 418-421.
4. Chaves, F., Barboza, M. and Gutiérrez, J. M. (1995) Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice. Toxicon 33, 31-39.
5. 2-induced oedema in rat paw. Eur. J. Pharmacol. 166, 505-510.
6. Cirino, G., Peers, S. H., Flower, R. J., Browning, J. L. and Pepinsky, R. B. (1989b) Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc. Natl. Acad. Sci. U.S.A. 86, 3428-3432.
7. 2 isoform isolated from Bothrops neuwiedii (yarará chica) venom with novel kinetic and chromatographic properties. Toxicon 35, 1205-1215.
8. 2 isolated from Bothrops asper and Bothrops godmani snake venoms: effects on enzymatic and pharmacological properties. Toxicon 35, 241-252.
9. 2, anticoagulant and myotoxic activities. Biochim. Biophys. Acta 1070, 455-460.
10. 2 from Bothrops godmani (Godman's pit viper) snake venom. Arch. Biochem. Biophys. 298, 135-142.
11. 2, affects its pharmacological activities. Toxicon 31, 1202-1206.
12. 2 variant, from Bothrops asper snake venom. Natural Toxins 3, 26-31.
13. Flower, R. J. (1988) Lipocortin and the mechanism of action of glucocorticoids. Br. J. Pharmacol. 94, 987-1015.
14. 2. Arch. Biochem. Biophys. 284, 352-359.
15. 2 myotoxins from Bothrops snake venoms. Toxicon 33, 1405-1424.
16. 2 enzymes. Structure, Function and Mechanism, ed. R. M. Kini, pp. 321-352. Wiley, Chichester.
17. Gutiérrez, J. M., Ownby, C. L. and Odell, G. V. (1984) Isolation of a myotoxin from Bothrops asper venom: partial characterization and action on skeletal muscle. Toxicon 22, 115-128.
18. Gutiérrez, J. M., Lomonte, B., Chaves, F., Moreno, E. and Cerdas, L. (1986) Pharmacological activities of a toxic phospholipase A isolated from the venom of the snake Bothrops asper. Comp. Biochem. Physiol. 84C, 159-164.
19. Gutiérrez, J. M., Avila, C., Rojas, E. and Cerdas, L. (1988) An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica. Toxicon 26, 411-413.
20. 2. Br. J. Pharmacol. 93, 145P.
21. Kaiser, I. I., Gutiérrez, J. M., Plummer, D., Aird, S. and Odell, G. V. (1990) The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper. Arch. Biochem. Biophys. 278, 319-325.
22. 2. Toxicon 27, 613-635.
23. 4. Nature 227, 680-685.
24. 2) no proceso inflamatorio. Atividade antiinflamatoria da crotapotina. Ph.D. thesis, Fundaçao Oswaldo Cruz, Rio de Janeiro, Brazil.
25. 2 homologue isolated from Bothrops pirajai snake venom. In Programas e Resumos da IV Simpósio da Sociedade Brasileira de Toxinología, p. 160.
26. 2 homolog from the venom of Trimeresurus mucrosquamatus. Biochim. Biophys. Acta 1077, 362-370.
27. Lomonte, B. and Gutiérrez, J. M. (1989) A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon 27, 725-733.
28. Lomonte, B., Tarkowski, A. and Hanson, L. A. (1993) Host response to Bothrops asper snake venom: analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation 17, 93-105.
29. 2 of Bothrops asper snake venom. Toxicon 32, 1359-1369.
30. 2 and inflammation. Molec. Med. Today 1, 9.
31. 2 - a mediator between proximal and distal effectors of inflammation. Immunol. Today 12, 143-146.
32. 2 covalently inhibited by p-bromophenacyl bromide. J. Molec. Biol. 200, 181-188.
33. Rosenberg, P. (1986) The relationship between enzymatic activity and pharmacological properties of phospholipases in natural poisons. In Natural Toxins, ed. J. B. Harris, pp. 129-174. Clarendon Press, Oxford.
34. Rosenberg, P. (1990) Phospholipases. In Handbook of Toxinology, ed. W. T. Shier and D. Mebs, pp. 67-277. Marcel Dekker, New York.
35. Trebien, H. A. and Calixto, J. B. (1989) Pharmacological evaluation of rat paw edema induced by Bothrops jararaca venom. Agents and Actions 26, 292-300.
36. 2 enzymes from Habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon 25, 501-515.
37. 2 from Vipera russelli (Russell's viper) snake venom. Toxicon 26, 713-720.
38. 2 enzymes. Eur. J. Pharmacol. 190, 347-354.